Clinical Ink

The Plight of the Site

Wednesday, March 1, 2017

Several months ago, Christine Pierre and I discussed the myriad burdens sites face as clinical research becomes ever more complex. We agreed that Clinical Ink and the Society for Clinical Research Sites (SCRS) shared the same desire to educate the industry about what I termed “the plight of the site.” To better understand how sites actually conduct research, Clinical Ink, SCRS and CenterWatch partnered to develop a comprehensive survey of site activities related to that critical moment in a clinical trial—the patient visit.

[Read More]

The need for—and barriers to—adopting eSource

Wednesday, February 15, 2017

Electronic data collection responsibility borne by investigative sites to support each clinical trial is onerous, with little to no relief in sight. In many instances, these responsibilities are being managed at the same time that paper data collection processes are prevalent.

[Read More]

Medidata introduces eConnect Partner Program

Monday, November 21, 2016

Medidata, a global provider of cloud-based solutions and data analytics for clinical research, has launched the Medidata eConnect Partner Program. The collaborative initiative will enable the seamless integration of healthcare data—from electronic health records (EHRs), electronic medical records (EMRs), and clinical trial electronic source data (eSource) systems—with the Medidata Clinical Cloud, a platform powering clinical trials for nearly 800 life sciences organizations worldwide.

[Read More]

Sites smothered by technology solutions

Sunday, May 1, 2016

Technology solutions help sponsors and CROs make better drug development decisions, streamline processes and reduce clinical trial costs. But for a majority of investigative sites, these same technologies get in the way of efficient operations and add to their already heavy workload.

[Read More]

Clinical Ink announces CentrosHealth Platform captures medical device data

Friday, July 24, 2015

Clinical Ink, a Winston-Salem, N.C.-based provider of eSource solutions for clinical trials, has updated CentrosHealth, a mobile patient engagement platform, to include streamlined connectivity for a wide range of medical devices. Medical device connectivity is powered by the 2net Mobile Platform from Qualcomm Life, a wholly owned subsidiary of Qualcomm Inc. This new platform was developed with cooperation from Novartis and PPD, which also are supporting a pilot clinical study before broad commercial use.

[Read More]

Clinical Ink merges with CentrosHealth

Thursday, March 19, 2015

Clinical Ink, a provider of eSource solutions for clinical trials with offices in Philadelphia, Pa., and Winston-Salem, N.C., has merged with CentrosHealth, a Boston-based provider of configurable mobile apps for clinical trial patient engagement and electronic patient reported outcomes (ePRO), founded by MPM Capital.

[Read More]